Search Count: 23
 |
Solution Structure Of Legionella Pneumophila Ntta
Organism: Legionella pneumophila
Method: SOLUTION NMR Release Date: 2020-07-22 Classification: UNKNOWN FUNCTION |
Organism: Legionella pneumophila
Method: SOLUTION NMR
Release Date: 2020-07-22
 |
Crystal Structure Of The Legionella Pneumophila Type Ii Secretion System Substrate Nttc
Organism: Legionella pneumophila 130b
Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2020-05-20 Classification: UNKNOWN FUNCTION Ligands: HOH |
Organism: Legionella pneumophila 130b
Method: X-RAY DIFFRACTION
Release Date: 2020-05-20
Ligands: HOH
 |
Crystal Structure Of The Legionella Pneumophila Type Ii Secretion System Substrate Ntte
Organism: Legionella pneumophila 130b
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2020-05-20 Classification: UNKNOWN FUNCTION Ligands: EDO |
Organism: Legionella pneumophila 130b
Method: X-RAY DIFFRACTION
Release Date: 2020-05-20
Ligands: EDO
 |
Crystal Structure Of The Legionella Pneumoppila Lapa
Organism: Legionella pneumophila
Method: X-RAY DIFFRACTION Resolution:1.87 Å Release Date: 2018-04-04 Classification: HYDROLASE Ligands: ZN |
Organism: Legionella pneumophila
Method: X-RAY DIFFRACTION
Release Date: 2018-04-04
Ligands: ZN
 |
Mre11 Dimer In Complex With Endonuclease Inhibitor Pfm04
Organism: Thermotoga maritima
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2018-03-07 Classification: hydrolase/hydrolase inhibitor Ligands: MN, BU7, EDO |
Organism: Thermotoga maritima
Method: X-RAY DIFFRACTION
Release Date: 2018-03-07
Ligands: MN, BU7, EDO
 |
Baff In Complex With Belimumab
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2018-02-21 Classification: PROTEIN BINDING |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-02-21
 |
Structure Of The Belimumab Fab Fragment
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2018-02-21 Classification: PROTEIN BINDING |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-02-21
 |
Crystal Structure Of Certolizumab Fab
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2017-06-07 Classification: IMMUNE SYSTEM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-06-07
 |
Tnfalpha-Certolizumab Fab
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2017-06-07 Classification: IMMUNE SYSTEM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-06-07
 |
Crystal Structure Of Nivolumab Fab Fragment
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2016-11-09 Classification: IMMUNE SYSTEM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-11-09
 |
Pd-1 In Complex With Nivolumab Fab
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.30 Å Release Date: 2016-11-09 Classification: IMMUNE SYSTEM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-11-09
 |
Pd-1 In Complex With Pembrolizumab Fab
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2016-11-09 Classification: IMMUNE SYSTEM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-11-09
 |
Pd-L1 In Complex With Bms-936559 Fab
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2016-11-09 Classification: IMMUNE SYSTEM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-11-09
 |
Crystal Structure Of Tremelimumab Fab
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.29 Å Release Date: 2016-11-09 Classification: IMMUNE SYSTEM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-11-09
 |
Ctla-4 In Complex With Tremelimumab Fab
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2016-11-09 Classification: IMMUNE SYSTEM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-11-09
 |
Crystal Structure Of Mtmr8
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2015-07-15 Classification: HYDROLASE Ligands: PO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-07-15
Ligands: PO4
 |
Dna Double-Strand Break Repair Pathway Choice Is Directed By Distinct Mre11 Nuclease Activities
Organism: Thermotoga maritima
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2014-01-15 Classification: DNA BINDING PROTEIN/inhibitor Ligands: 2Q0, MN |
Organism: Thermotoga maritima
Method: X-RAY DIFFRACTION
Release Date: 2014-01-15
Ligands: 2Q0, MN
 |
Dna Double-Strand Break Repair Pathway Choice Is Directed By Distinct Mre11 Nuclease Activities
Organism: Thermotoga maritima
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2014-01-08 Classification: HYDROLASE Ligands: MN |
Organism: Thermotoga maritima
Method: X-RAY DIFFRACTION
Release Date: 2014-01-08
Ligands: MN
 |
Dna Double-Strand Break Repair Pathway Choice Is Directed By Distinct Mre11 Nuclease Activities
Organism: Thermotoga maritima
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2014-01-08 Classification: DNA BINDING PROTEIN/inhibitor Ligands: MN, 2PW |
Organism: Thermotoga maritima
Method: X-RAY DIFFRACTION
Release Date: 2014-01-08
Ligands: MN, 2PW
 |
Dna Double-Strand Break Repair Pathway Choice Is Directed By Distinct Mre11 Nuclease Activities
Organism: Thermotoga maritima
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2014-01-08 Classification: DNA BINDING PROTEIN/inhibitor Ligands: MN, 2PK |
Organism: Thermotoga maritima
Method: X-RAY DIFFRACTION
Release Date: 2014-01-08
Ligands: MN, 2PK